Medicines
Find medicines for human use by name or active substance.
Browse by initial
Medicines beginning with A
1,241–1,260 of 2,168 medicines
-
-
-
-
ANAFRANIL 10mg sugar-coated tablets NOVARTIS
Active substance: clomipramine
N06AA04 Nervous system | Antidepressants | Non-selective monoamine reuptake inhibitors
Indicated for: depression; obsessive-compulsive disorder
-
ANAFRANIL 25mg sugar-coated tablets NOVARTIS
Active substance: clomipramine
N06AA04 Nervous system | Antidepressants | Non-selective monoamine reuptake inhibitors
Indicated for: depression; obsessive-compulsive disorder
-
ANAGRELIDA ACCORD 0.5mg capsules
Active substance: anagrelide
L01XX35 Antineoplastic and immunomodulating agents | Other antineoplastic agents
Indicated for: essential thrombocythemia
-
ANAGRELIDA ACCORD 1mg capsules
Active substance: anagrelide
L01XX35 Antineoplastic and immunomodulating agents | Other antineoplastic agents
Indicated for: essential thrombocythemia
-
ANAGRELIDA AOP 0.5mg capsules AOP ORPHAN
Active substance: anagrelide
L01XX35 Antineoplastic and immunomodulating agents | Other antineoplastic agents
Indicated for: essential thrombocythemia
-
ANAGRELIDA AUROBINDO 0.5mg capsules
Active substance: anagrelide
L01XX35 Antineoplastic and immunomodulating agents | Other antineoplastic agents
Indicated for: essential thrombocythemia
-
ANAGRELIDA DR REDDY'S 0.5mg capsules DR. REDDY'S
Active substance: anagrelide
L01XX35 Antineoplastic and immunomodulating agents | Other antineoplastic agents
Indicated for: essential thrombocythemia
-
ANAGRELIDA GLENMARK 0.5mg capsules
Active substance: anagrelide
L01XX35 Antineoplastic and immunomodulating agents | Other antineoplastic agents
Indicated for: essential thrombocythemia
-
ANAGRELIDA MYLAN 0.5mg capsules
Active substance: anagrelide
L01XX35 Antineoplastic and immunomodulating agents | Other antineoplastic agents
Indicated for: essential thrombocythemia
-
ANAGRELIDA MYLAN 1mg capsules
Active substance: anagrelide
L01XX35 Antineoplastic and immunomodulating agents | Other antineoplastic agents
Indicated for: essential thrombocythemia
-
ANAGRELIDA NORDIC 0.5mg tablets NORDIC GROUP
Active substance: anagrelide
L01XX35 Antineoplastic and immunomodulating agents | Other antineoplastic agents
Indicated for: essential thrombocythemia
-
ANAGRELIDA NORDIC 0.75mg tablets NORDIC GROUP
Active substance: anagrelide
L01XX35 Antineoplastic and immunomodulating agents | Other antineoplastic agents
Indicated for: essential thrombocythemia
-
ANAGRELIDA NORDIC 1.0mg 1mg tablets NORDIC GROUP
Active substance: anagrelide
L01XX35 Antineoplastic and immunomodulating agents | Other antineoplastic agents
Indicated for: essential thrombocythemia
-
ANAGRELIDA SANDOZ 0.5mg capsules
Active substance: anagrelide
L01XX35 Antineoplastic and immunomodulating agents | Other antineoplastic agents
Indicated for: essential thrombocythemia
-
ANAGRELIDA TERAPIA 0.5mg capsules
Active substance: anagrelide
L01XX35 Antineoplastic and immunomodulating agents | Other antineoplastic agents
Indicated for: essential thrombocythemia
-
ANAGRELIDA TEVA 0.5mg capsules
Active substance: anagrelide
L01XX35 Antineoplastic and immunomodulating agents | Other antineoplastic agents
Indicated for: essential thrombocythemia
-
ANAGRELIDA ZENTIVA 0.5mg capsules
Active substance: anagrelide
L01XX35 Antineoplastic and immunomodulating agents | Other antineoplastic agents
Indicated for: essential thrombocythemia
About medicines
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.